Report description
Omega-3 is polyunsaturated fatty acids (PUFAs) which includes α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are the dietary lipid supplements which are extremely helpful in maintaining the health condition in cardiovascular disease, diabetes, cancer, depression and various mental illnesses, age-related cognitive decline, and rheumatoid arthritis. These are present in certain foods such as flaxseed, algae and fishes. Dietary supplements are not medicines, nor should they be considered as a substitute for food. These fatty acids are majorly consumed with a prime intention to enhance the intake of essential nutritional components in the human body. Growing prevalence of cardiovascular disorders on account of fluctuating diet patterns and inactive lifestyle among the age-group of 30-40 is expected to promote the importance of Nutraceuticals. The Omega-3 PUFA market was valued at
USD 58.16 billion in 2024, registering a
CAGR of 7.2%, during the forecast period (
2019-2024). The Omega-3 PUFA market is preliminarily driven by the paradigm shift towards preventive health management practices, amid rising healthcare costs and increasing burden of lifestyle diseases. The SPER market research report of Omega-3 PUFA includes all integrated approach to growth of the market along with an elaborate & accurate analysis of the complete competitive situation of this market on a global level with the key market trends & newest technologies, being a major part in the growth during the estimated period. Besides the current analytical & statistical account, the report cloaks the trends market drivers, challenges, potential opportunities, which have an effect on the market. This market report discusses the present situation to predicted trends & aspects of the growth of Omega-3 PUFA market. Furthermore, it gives a dynamic overview & insights related to the market at both global as well as regional scale. Moreover, the popularity of lipid supplements is also expected to drive the market growth in the future.
Based on product type, the ALA Omega-3 is steadily growing, whereas the market of DHA Omega-3 is the most dominating among all three types of Omega-3, also the maximum market revenue is shared by DHA & ALA in 2016 and the remaining market is for EPA Omega-3. North America is the biggest market with constantly increasing CAGR for Omega-3 PUFA Supplements. The growth exhibited by the global Omega-3 PUFA market is a result of various factors such as the increasing the health awareness and inclination towards the natural and organic food supplements, developing economies and subsequently increasing income of consumer, increasing demand from the Asia-Pacific Countries, hectic lifestyle, increasing geriatric population, and spread of chronic ailments also the major reason is the use of Omega-3 in the formulation of infant supplements. With an increase in the aging populations in the high-income economies such as the U.S., the U.K., Germany, and Japan, more and more people are looking for preventive healthcare management, thereby keeping diseases at bay. Growing awareness towards the importance of functional foods on account of providing optimal health and reducing the risk of cholesterol diseases is expected to increase the application scope of Omega-3 Supplements. Also, the high cost involved in the Research & Development is the major restraints in the market growth of these supplements.